Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Other 1Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Lymphoma 1730Lymphoma, Non-Hodgkin 1205Leukemia, Lymphocytic, Chronic, B-Cell 1120Lymphoma, Follicular 1067Lymphoma, Large B-Cell, Diffuse 1060Hodgkin Disease 906Leukemia 877Lymphoma, Mantle-Cell 738Leukemia, Myeloid, Acute 662Burkitt Lymphoma 604Multiple Myeloma 556Lymphoma, B-Cell, Marginal Zone 546Myelodysplastic Syndromes 507Recurrence 451Lymphoma, B-Cell 415Lymphoma, Large-Cell, Immunoblastic 328Waldenstrom Macroglobulinemia 323Lymphoma, T-Cell, Cutaneous 322Mycosis Fungoides 277Neoplasms 257Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 249Myeloproliferative Disorders 249Neoplasms, Plasma Cell 242Sezary Syndrome 231Leukemia, Myelogenous, Chronic, BCR-ABL Positive 221Lymphoma, Large-Cell, Anaplastic 215Leukemia, Myeloid, Accelerated Phase 211Lymphoma, T-Cell, Peripheral 205Blast Crisis 203

Interventions

rasburicase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Hyperuricemia × Lymphoid × Clear all
NCT00186940 2017-04-25

Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients

St. Jude Children's Research Hospital

Completed
16 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Tumor Lysis Syndrome, Hyperuricemia

NCT00628628 2013-08-01

Rasburicase in Patients at Risk for Tumor Lysis Syndrome

M.D. Anderson Cancer Center

Phase 2 Completed
82 enrolled 6 charts
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Tumor Lysis Syndrome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡